Marks & Clerk is excited to host the Genesis Fringe event on Tuesday 3 December 2024, at our London office. This engaging session will focus on the IP landscape in advanced therapy, offering valuable insights for emerging companies aiming to strengthen their appeal to R&D partners and investors through strong IP strategies.
The event will feature a panel discussion with industry experts who will delve into key topics, including:
• Building an effective IP strategy.
• Conducting comprehensive Freedom to Operate (FTO) searches.
• Navigating conflicts with third-party IP.
Marks & Clerk’s own Will Arends will be among the distinguished panellists, contributing his expertise to this thought-provoking conversation.
For more information please visit: https://onenucleus.com/civicrm/event/info?reset=1&id=1818